A Study of Sustained Virological Response in Relation to IL28-b Expression in Treatment-Na√Øve Patients With Chronic Hepatitis C Genotype 1 on Combination Treatment With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)